Factors influencing serum concentrations of soluble interleukin-2 receptor: a general adult population study

References

• Adult Treatment Panel III. 2001. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA: The Journal of the American Medical Association. 285:2486–2497. doi:10.1001/jama.285.19.2486
   PubMed Web of Science ®Google Scholar
• Alende-Castro V, et al. 2019. Factors influencing erythrocyte sedimentation rate in adults. Medicine (Baltimore). 98:e16816. doi:10.1097/MD.0000000000016816
   PubMed Web of Science ®Google Scholar
• Alende-Castro V, et al. 2021b. C-Reactive protein versus erythrocyte sedimentation rate: implications among patients with no known inflammatory conditions. J Am Board Fam Med. 34:974–983. doi:10.3122/jabfm.2021.05.210072
   PubMed Web of Science ®Google Scholar
• Alende-Castro V, et al. 2021. Serum concentrations of interleukin 6 in the general adult population: possible implications for anti–IL-6 therapy in SARS-Cov-2 infection and IL-6–related diseases. J Investig Allergol Clin Immunol. 31:75–78. doi:10.18176/jiaci.0601
   PubMed Web of Science ®Google Scholar
• Chen LYC, et al. 2021. Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome. Cell Reports Medicine. 2:100269. doi:10.1016/j.xcrm.2021.100269
   PubMedGoogle Scholar
• Damoiseaux J. 2020. The IL-2 - IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor. Clin Immunol. 218:108515. doi:10.1016/j.clim.2020.108515
   PubMed Web of Science ®Google Scholar
• Dik WA, Heron M. 2020. Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases. Neth J Med. 78:220–231.
   PubMed Web of Science ®Google Scholar
• Durda P, et al. 2015. Plasma levels of soluble interleukin-2 receptor α. Arterioscler Thromb Vasc Biol. 35:2246–2253. doi:10.1161/ATVBAHA.115.305289
   PubMed Web of Science ®Google Scholar
• Hayden A, et al. 2017. Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH. Blood Adv. 1:2529–2534. doi:10.1182/bloodadvances.2017012310
   PubMed Web of Science ®Google Scholar
• Kuuliala A, et al. 2006. Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab. Ann Rheum Dis. 65:26–29. doi:10.1136/ard.2004.034728
   PubMed Web of Science ®Google Scholar
• Lassalle P, et al. 1992. Levels of soluble IL-2 receptor in plasma from asthmatics. correlations with blood eosinophilia, lung function, and corticosteroid therapy. Clin Exp Immunol. 87:266–271. doi:10.1111/j.1365-2249.1992.tb02986.x
   PubMed Web of Science ®Google Scholar
• Lin M, et al. 2017. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review. Ann Hematol. 96:1241–1251. doi:10.1007/s00277-017-2993-y
   PubMed Web of Science ®Google Scholar
• Liuzzo G, Rizzello V. 2001. C-reactive protein and primary prevention of ischemic heart disease. Clin Chim Acta. 311:45–48. doi:10.1016/S0009-8981(01)00557-5
   PubMed Web of Science ®Google Scholar
• Manoussakis MN, et al. 1990. Soluble interleukin-2 receptors and auto antibodies in the serum of healthy elderly individuals. Autoimmunity. 7:129–137. doi:10.3109/08916939008993385
   PubMed Web of Science ®Google Scholar
• Matsumoto T, et al. 1991. Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases. Clin Exp Immunol. 85:288–292. doi:10.1111/j.1365-2249.1991.tb05720.x
   PubMed Web of Science ®Google Scholar
• McMurray RW, et al. 2001. 17-β-estradiol suppresses IL-2 and IL-2 receptor. Cytokine. 14:324–333. doi:10.1006/cyto.2001.0900
   PubMed Web of Science ®Google Scholar
• Miller AL, et al. 1996. Serum levels of the soluble low affinity receptor for IgE and soluble interleukin-2 receptor in childhood, and their relation to age, gender, atopy and allergic disease. Pediatr Allergy Immunol. 7:68–74. doi:10.1111/j.1399-3038.1996.tb00109.x
   PubMed Web of Science ®Google Scholar
• Morita-Fujita M, et al. 2019. High level of serum soluble interleukin-2 receptor is associated with poor survival in patients with first relapsed or refractory peripheral T-cell lymphoma, not otherwise specified: A retrospective study. Clin Lymphoma Myeloma Leuk. 19:e337–e342. doi:10.1016/j.clml.2019.03.031
   PubMed Web of Science ®Google Scholar
• Natali A, et al. 2003. Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality. Eur Heart J. 24:639–648. doi:10.1016/S0195-668X(02)00741-8
   PubMed Web of Science ®Google Scholar
• Nozaki K, et al. 2020. Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphoma. Leuk Lymphoma. 61:2113–2121. doi:10.1080/10428194.2020.1759054
   PubMed Web of Science ®Google Scholar
• Quartuccio L, et al. 2021. Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia. Cytokine. 140:155438. doi:10.1016/j.cyto.2021.155438
   PubMed Web of Science ®Google Scholar
• Rothkrantz-Kos S, et al. 2004. Reference values of soluble interleukin-2 receptor on the IMMULITE. Clin Chem Lab Med. 42:976–977.
   PubMed Web of Science ®Google Scholar
• Rubin LA, Nelson DL. 1990. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med. 113:619–627. doi:10.7326/0003-4819-113-8-619
   PubMed Web of Science ®Google Scholar
• Terao K, Fukase Y. 1991. Effects of hyperlipaemic serum on interleukin-2 (IL-2) production, IL-2 receptor expression, and T cell proliferation induced by IL-2 in cynomolgus monkeys. Jpn J Med Sci Biol. 44:17–28. doi:10.7883/yoken1952.44.17
   PubMedGoogle Scholar
• Teraura H, et al. 2017. The serum concentration of soluble interleukin-2 receptor in patients with kawasaki disease. Ann Clin Biochem. 54:209–213. doi:10.1177/0004563216677583
   PubMed Web of Science ®Google Scholar
• Thi Hong Nguyen C, et al. 2017. Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement. J Dermatol. 44:789–797. doi:10.1111/1346-8138.13792
   PubMed Web of Science ®Google Scholar
• Tollerud DJ, et al. 1992. Elevated soluble lnterleukin-2 receptors in young healthy cigarette smokers: lack of association with atopy or airways hyperresponsiveness. Int Arch Allergy Appl Immunol. 97:25–30. doi:10.1159/000236091
   Google Scholar
• van Stigt AC, et al. 2021. Soluble interleukin-2 receptor is a promising serum biomarker for granulomatous disease in common variable immune deficiency. J Clin Immunol. 41:694–697. doi:10.1007/s10875-020-00947-8
   PubMed Web of Science ®Google Scholar
• Zoref-Lorenz A, et al. 2022. An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis. Blood. 139:1098–1110. doi:10.1182/blood.2021012764
   PubMed Web of Science ®Google Scholar